Hippocampal volume and antidepressant response in geriatric depression

International Journal of Geriatric Psychiatry

Volumn 17, Issue 6, 2002, Pages 519-525

  Hsieh, Ming Hong ^a   McQuoid, Douglas R ^b   Levy, Robert M ^b   Payne, Martha E ^b   MacFall, James R ^b   Steffens, David C ^b  

^a Dental College Hospital   (Taiwan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Depression; Elderly; Hippocampus; Outcome; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AGE; AGED; ANAMNESIS; ARTICLE; BRAIN REGION; BRAIN SIZE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEPRESSION; DRUG RESPONSE; FEMALE; GERIATRIC DISORDER; HIPPOCAMPUS; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROSCIENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PSYCHIATRIST; RATING SCALE; REMISSION; STANDARD; STANDARDIZATION; TREATMENT OUTCOME;

AGED; AGING; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG RESISTANCE; FEMALE; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0036089397     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.611     Document Type: Article

References (28)

1. Hippocampal volume reduction in major depression
2. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility
3. Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician
4. Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: Results from a double-blind, randomized, controlled clinical trial
5. A rating scale for depression
6. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression - A longitudinal evaluation
7. Alternative models of the stress buffering hypothesis
8. Clinical and neuroradiologic features associated with chronicity in late-life depression
9. Cortisol levels during human aging predict hippocampal atrophy and memory deficits
10. Relative accuracy and reproducibility of regional MRI brain volumes for point-counting methods
11. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response
12. Quantative MRI of the hippocampus and amygdala in severe depression
13. The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments
14. A new depression scale designed to be sensitive to change
15. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: Follow up study
16. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
17. National Institute of Mental Health diagnostic interview schedule
18. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
19. Sustained response to open-label venlafaxine in drug-resistant major depression
20. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression
21. Hippocampal atrophy in recurrent major depression
22. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression
23. 1997 IPA/Bayer research awards in psychogeriatrics subcortical hyperintensities in late-life depression: Acute response to treatment and neuropsychological impairment
24. Hippocampal volume in geriatric depression
25. Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression
26. Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study
27. Hippocampal volume in primary unipolar major depression: A magnetic resonance imaging study
28. The 3-year course and outcome of patients with major depression and silent cerebral infarction